Skip to main content
Log in

Activity of decitabine in pericardial myeloid sarcoma

  • Images in Hematology
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Gautam A, Jalali GK, Sahu KK, Deo P, Ailawadhi S. Cardiac myeloid sarcoma: review of literature. J Clin Diagn Res. 2017;11(3):XE01–04.

    PubMed  PubMed Central  Google Scholar 

  2. Gornicec M, Wolfler A, Stanzel S, Sill H, Zebisch A. Evidence for a role of decitabine in the treatment of myeloid sarcoma. Ann Hematol. 2017;96(3):505–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

DE and WJFMV wrote the manuscript. MG prepared the PET images. All authors were involved in the patient’s treatment. All authors revised and approved the final manuscript.

Corresponding author

Correspondence to Walter J. F. M. van der Velden.

Ethics declarations

Conflict of interest

None of the authors has a conflict of interest to report in relation to this manuscript.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Evers, D., Bär, B.M.A.M., Gotthardt, M. et al. Activity of decitabine in pericardial myeloid sarcoma. Int J Hematol 108, 121–122 (2018). https://doi.org/10.1007/s12185-018-2470-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-018-2470-y

Keywords

Navigation